# PTX Capital

> PTX Capital is a VC fund in Baltimore backing Medical, Health Care and Biotechnology. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Baltimore, United States
- Total investments: 8
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ptx-capital
- Website: https://ptxcap.com/

PTX Capital is a venture capital and private equity investment firm. It was established in 2021.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 5 | 63% |
| Health Care | 4 | 50% |
| Biotechnology | 3 | 38% |
| mHealth | 2 | 25% |
| Health Diagnostics | 2 | 25% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 38% |
| Series A | 3 | 38% |
| Series B | 2 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Inner Logic | Inner Logic serves as the development infrastructure for the next generation of procedural devices, including orthopedic implants, heart valves, and surgical robots. | $11.5M | Seed | Jul 22, 2026 |  |
| Infinity Bio | Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses. | $8M | Series A | Jun 18, 2025 |  |
| Pair Team | Pair Team is on a mission to build the primary care infrastructure for America’s most vulnerable communities.They are the first tech-enabled care team that empowers safety-net primary care systems and the Medicaid & Medicare patients they serve. They act as an extension of the clinical staff to provide a personalized, high-touch careexperience while addressing patients' barriers to care such as lack of transportation, housing/food insecurity, and mobile phone access. Internally, they are building a unique care delivery platform to ensure clinical best practices, integrate care with community-based organizations, and automate administrative work so that clinicians can focus on time with our patients. | $9M | Series A | Oct 19, 2023 |  |
| Scene Health | Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Scene Health's 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivationalcontent, its bringd healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Scene Health's mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. The company makes it fun for patients to stay on top of their medications, help them address any medication challenges, and empowers them to improve their health by identifying and addressing barriers to adherence related to social determinants of health. Over 120 customers across the healthcare landscape use our medication engagement program to improve medication adherence for patients with chronic and infectious diseases. | $17.7M | Series B | Apr 12, 2023 |  |
| Delfi Diagnostics | Delfi Diagnostics detect cancer early, when it is most curable, using high precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. | $225M | Series B | Jul 18, 2022 |  |
| ArrePath | ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. | $20M | Seed | Mar 03, 2022 |  |
| Sonavi Labs | Sonavi Labs is an innovative device and software company that focuses on developing modern medical products that analyze body sounds for the diagnosis of diseases. The company creates technology rooted in artificial intelligence that will evolve the patient experience and enhance the capabilities of providers.It was founded in 2017 andheadquartered in Baltimore, Maryland. | $3.5M | Seed | Sep 29, 2021 |  |
| Scene Health | Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Scene Health's 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivationalcontent, its bringd healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Scene Health's mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. The company makes it fun for patients to stay on top of their medications, help them address any medication challenges, and empowers them to improve their health by identifying and addressing barriers to adherence related to social determinants of health. Over 120 customers across the healthcare landscape use our medication engagement program to improve medication adherence for patients with chronic and infectious diseases. | $6.2M | Series A | May 18, 2021 |  |

8 of 8 investments shown.

## Co-investors
- [Kapor Capital](https://shizune.co/investors/profile/kapor-capital) — VC Fund, 3 deals together
- Claritas Health Ventures — VC Fund, 2 deals together
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 2 deals together
- Healthworx — VC Fund, 2 deals together
- [Illumina Ventures](https://shizune.co/investors/profile/illumina-ventures) — VC Fund, 2 deals together
- [ABS Capital Partners](https://shizune.co/investors/profile/abs-capital-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does PTX Capital invest in?

PTX Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did PTX Capital last invest?

The most recent investment recorded for PTX Capital closed in Jul 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co